UroGen Pharma Ltd. Ordinary Shares (NASDAQ: URGN) last traded at $36.83, down 0.41% on the session. The quote above updates while this page is open; the figures below are drawn from UroGen Pharma Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
UroGen Pharma Ltd. Ordinary Shares trades on NASDAQ under the ticker URGN. Its market capitalisation is $1.80 billion.
Valuation measures for UroGen Pharma Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.80B |
|---|---|
| Enterprise value | $2.11B |
| Price / sales | 9.54 |
| Beta | 1.28 |
Trailing-twelve-month figures tagged in UroGen Pharma Ltd. Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $188.73M |
| Net income (TTM) | -$97.64M |
|---|
| EPS (TTM) | -$1.97 |
|---|
| Gross margin | 90.85% |
|---|
| Operating margin | -35.32% |
|---|
| Cash | $79.13M |
|---|
Range and volume for URGN over the past 52 weeks.
| 52-week high | $50.81 |
|---|---|
| 52-week low | $16.18 |
| Volume | 3.90M |
| Average volume | 895.9K |
| Previous close | $36.98 |
Invest a chosen dollar amount in UroGen Pharma Ltd. Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell URGN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.